2009.10.01 Weekly Broadcast Email
The following updates were made to the website for the week of September 28, 2009.
Thank you to everyone for making the Annual Research Base Meeting in Asheville, NC a great success! The meeting handouts and presentations can be found on the annual meeting section of our website. We look forward to seeing you all again next year in Wilmington, NC.
Note: The link for part 2 of Saturday’s presentations will be live tomorrow morning. All other links are functioning.
The following adverse events were reported during the month of September. A PDF of the AE document has been attached to this email and a summary of the event can be found on the adverse event page of the website.
In the month of September, 8 patients were accrued to CCCWFU CCOP Research Base trials. SCCC was the top accruing site with 4 patients. See the Research Base home page for further information.
97202 Randomized Double-Blind Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Cancer Treatment Related Fatigue in Breast Cancer Patients
2009 CR Approval Letter added to the website.
Featured Study: Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients
Have you considered opening 91105 at your site? Has your site accrued patients to this study recently? You might be interested to know…
Several recent protocol changes have been made to study 91105, Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients. These changes were made to facilitate and simplify enrollment which include:
-Adding a $40 gift for participating
-Simplifying and reducing medication exclusions
Visit the recently updated 91105 webpage to view:
• Letter from the PI, Dr. Steve Rapp
• Brochure outlining recent changes
• Training video
97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 10 minority accrual slots open for patient accruals. We would like to see this study close by the end of the summer, so if you have patients that may be eligible for this study, please try and get them registered by then.
Wake Forest University Baptist Medical Center
Department of Radiation Oncology
Research Base Protocol Information Office
2000 West First Street, Suite 401
Winston-Salem, NC 27104
Pager: 336-716-2440, ID number 1689